Patents by Inventor Stephen A. Howard

Stephen A. Howard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12249226
    Abstract: An inventory system, apparatus and method. The method to be used in a cooler that includes a power module provides power to the inventory system from an electric source, battery, WIFI charge, wireless charge and/or combination thereof, a computer processor coupled to the power module, a memory module coupled to the computer processor, an image capturing module coupled to the processor, a movement module coupled to the processor; wherein the movement module triggers the image capturing device to capture images of products in a cooler due to a movement.
    Type: Grant
    Filed: November 15, 2023
    Date of Patent: March 11, 2025
    Assignee: Omni Consumer Products, LLC
    Inventor: Stephen Howard
  • Patent number: 12246049
    Abstract: This disclosure relates to modified viruses, e.g., oncolytic vaccinia viruses, which have been modified to contain an exogenous nucleic acid that expresses a protein that modulates STAT3 activity. It is based, at least in part, on the discovery that vaccinia viruses modified to contain nucleic acid encoding PIAS3 and that express PIAS3 or a fragment thereof can inhibit STAT3 activity and enhance the anti-cancer activity of the vaccinia virus. Accordingly, this disclosure provides for oncolytic vaccinia viruses and methods of using them in the treatment of cancers.
    Type: Grant
    Filed: August 18, 2023
    Date of Patent: March 11, 2025
    Assignee: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
    Inventors: Stephen Howard Thorne, Daniel J. Byrd
  • Publication number: 20250064873
    Abstract: The present disclosure provides for compositions comprising nucleic acids encoding for fusion proteins of the Tumor Necrosis Factor Super Family Ligands fused to oligomerization domains. Further provided are viral and non-viral vectors for delivery of such compositions. The present disclosure also provides for compositions comprising fusion proteins of the Tumor Necrosis Factor Super Family Ligands fused to oligomerization domains.
    Type: Application
    Filed: December 12, 2023
    Publication date: February 27, 2025
    Inventors: Stephen Howard THORNE, Mingrui ZHANG
  • Publication number: 20250041368
    Abstract: The disclosure relates to modified oncolytic viruses. The modified oncolytic viruses of the disclosure comprise modification in the viral genome encoding exogenous nucleic acids to enhance the oncolytic immunotherapy by remodeling the tumor microenvironment and with enhanced systemic delivery. The disclosure further relates to compositions comprising the modified oncolytic viruses, kits containing the same, and methods of using the oncolytic viruses.
    Type: Application
    Filed: September 23, 2024
    Publication date: February 6, 2025
    Inventors: Stephen Howard THORNE, Mingrui ZHANG, Daniel J. BYRD
  • Publication number: 20250044915
    Abstract: A curved screen skylight for an aircraft includes a curved display screen which is configured to display imagery provided from a camera positioned on the aircraft or preloaded imagery stored on a memory storage device. The curved screen display conforms to an aircraft overhead panel and can be secured using flanges extending from the overhead panel.
    Type: Application
    Filed: July 25, 2024
    Publication date: February 6, 2025
    Inventors: Joshua Lawrence Bell, Stephen Howard Fagan, Michael Scott Robinson, Matthew R. Harrell
  • Publication number: 20250030127
    Abstract: The present disclosure provides an anode assembly for a battery cell. The battery cell comprises a separator layer, an anode layer, an anode current collector, and a seal. The anode layer is at least partially disposed on the separator layer and has a first surface facing the separator layer, a second surface facing away from the separator layer, and an outer surface extending from the first surface to the second surface. The anode layer comprises a solid-state electrolyte (SSE) having pores. The anode current collector is coupled to the second surface of the anode layer. The seal is substantially impervious to liquid. The present disclosure also provides methods of forming an anode assembly for a battery cell.
    Type: Application
    Filed: November 9, 2022
    Publication date: January 23, 2025
    Inventors: Elizabeth A. SANTORI, Nicholas S. HUDAK, Mara A. TOLKSDORF, Gregory Thomas HITZ, Timothy Robert CURRIE, Marissa Michelle BRADLEY, Connor Jackson LEACH, Diana Marie LUTZ, Rahul JAY, Geoffrey Stephen HOWARD
  • Publication number: 20250009824
    Abstract: The disclosure relates to modified oncolytic viruses. The modified oncolytic viruses of the disclosure comprise modification in the viral genome encoding exogenous nucleic acids to enhance the oncolytic immunotherapy by remodeling the tumor microenvironment and with enhanced systemic delivery. The disclosure further relates to compositions comprising the modified oncolytic viruses, kits containing the same, and methods of using the oncolytic viruses.
    Type: Application
    Filed: September 23, 2024
    Publication date: January 9, 2025
    Inventors: Stephen Howard THORNE, Mingrui ZHANG, Daniel J. BYRD
  • Patent number: 12150969
    Abstract: A method of modifying a virus for in vivo delivery to a region of interest includes forming an enveloping composition including a lipid conjugate formed by conjugating at least one lipid with at least one hydrophilic compound via a linkage which is cleavable under conditions present in the region of interest and combining the virus with the enveloping composition to encompass the virus within the enveloping structure.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: November 26, 2024
    Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
    Inventors: Song Li, Stephen Howard Thorne
  • Patent number: 12120471
    Abstract: An interactive projection system and method comprising a camera/projector unit having a computer processor connected via a network to a content server and content database. The system projects interactive trigger areas on a three-dimensional object. Specific content stored on the content server or locally in the memory of the computer processor is associated with each trigger area. A user interacts with the trigger areas and the system projects informational or entertainment content about the object on the surface of the object.
    Type: Grant
    Filed: January 24, 2022
    Date of Patent: October 15, 2024
    Assignee: Omni Consumer Products, LLC
    Inventor: Stephen Howard
  • Patent number: 12082522
    Abstract: An includes a soil-sensing arrangement. The apparatus (1) includes a seed-delivery mechanism. The soil-sensing arrangement includes one or more soil-sensing elements. Each of the one or more soil-sensing elements senses one or more conditions of the soil. The one or more soil-sensing elements can take the form of one or more soil-sensing tines (19). In the method, material is delivered to a locally-optimised soil depth LOD. In the method, there is at least periodic sensing of one or more conditions of the soil, and at two or more depths at mutually differing proximities to the locally-optimised depth.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: September 10, 2024
    Assignee: Sensortine Pty Ltd
    Inventors: Davidson Alexander Finlay, Wendy Louise Finlay, Paul Andrew Mullins, Gordon Stephen Howard
  • Publication number: 20240277794
    Abstract: The present disclosure provides for recombinant oncolytic viruses with gene deletions or insertions which result in downregulation of Major Histocompatibility Complex class I and alternatively or additively upregulation of Major Histocompatibility Complex class II. Immunologic and pharmaceutical compositions comprising these recombinant viruses and methods of using these compositions are also presented.
    Type: Application
    Filed: April 18, 2024
    Publication date: August 22, 2024
    Inventors: Stephen Howard THORNE, Mingrui ZHANG
  • Publication number: 20240277793
    Abstract: The present disclosure provides for recombinant oncolytic viruses with gene deletions or insertions which result in downregulation of Major Histocompatibility Complex class I and alternatively or additively upregulation of Major Histocompatibility Complex class II. Immunologic and pharmaceutical compositions comprising these recombinant viruses and methods of using these compositions are also presented.
    Type: Application
    Filed: March 15, 2024
    Publication date: August 22, 2024
    Inventors: Stephen Howard THORNE, Mingrui ZHANG
  • Publication number: 20240252116
    Abstract: Devices, systems, and methods for quantifying applied pressure by a device against an area of tissue. In particular, the present technology is related to medical devices including an optical element with a fiber Bragg grating, systems including the medical devices, and methods of quantifying applied pressure by the medical device. In one embodiment, a medical device comprises an elongate body including a distal portion and a proximal portion opposite the distal portion, and an optical element located at the distal portion of the elongate body. In one embodiment, the optical element include an optical fiber with a fiber Bragg grating. In one embodiment, the medical device is part of a medical system comprising a control unit in communication with the medical device, the control unit including an optical interrogator in communication with the optical element and processing circuitry configured to receive data from the optical interrogator.
    Type: Application
    Filed: April 10, 2024
    Publication date: August 1, 2024
    Inventors: Stephen Howard, Carl Schu
  • Patent number: 12029467
    Abstract: A method and system for creating permanent lesions in an area of target tissue, such as tissue at or proximate a junction between a pulmonary vein and the left atrium. The method may generally include positioning a medical device in contact with a pulmonary vein ostium, ablating the tissue, and recording a plurality of temperature measurements from one or more of three temperature sensors. The device may include an occlusion element in communication with a coolant source, a first sensor located distal of the occlusion element, a second sensor located proximal of the occlusion element, and a third sensor located in the occlusion element. One or more temperature measurements may be compared with each other to assess occlusion of the pulmonary vein, and/or may be compared with a set of reference temperatures to predict a real-time temperature within the target tissue.
    Type: Grant
    Filed: November 16, 2021
    Date of Patent: July 9, 2024
    Assignee: Medtronic CryoCath LP
    Inventors: Dan Wittenberger, Jean-Pierre Lalonde, Stephen A. Howard
  • Publication number: 20240207562
    Abstract: A system for delivering respiratory therapy to a patient includes a patient interface device for delivering pressurized gas to a patient, a connector system for connection to a source of pressurized gas and a conduit system fluidly connecting the connector system to the patient interface device. The connector system includes a plurality of closable ports that allow a plurality of different modes of respiratory therapy to be provided. The conduit system may include a first gas line, a second gas line and a third gas line. The second gas line and third gas line may be contained within the first gas line along at least part of their length.
    Type: Application
    Filed: March 4, 2024
    Publication date: June 27, 2024
    Inventor: Stephen Howard
  • Publication number: 20240207561
    Abstract: A system for delivering respiratory therapy to a patient includes a patient interface device for delivering pressurized gas to a patient, a connector system for connection to a source of pressurized gas and a conduit system fluidly connecting the connector system to the patient interface device. The connector system includes a plurality of closable ports that allow a plurality of different modes of respiratory therapy to be provided. The conduit system may include a first gas line, a second gas line and a third gas line. The second gas line and third gas line may be contained within the first gas line along at least part of their length.
    Type: Application
    Filed: March 4, 2024
    Publication date: June 27, 2024
    Inventor: Stephen Howard
  • Patent number: 12016893
    Abstract: The present disclosure provides for recombinant oncolytic viruses with gene deletions or insertions which result in downregulation of Major Histocompatibility Complex class I and alternatively or additively upregulation of Major Histocompatibility Complex class II. Immunologic and pharmaceutical compositions comprising these recombinant viruses and methods of using these compositions are also presented.
    Type: Grant
    Filed: December 13, 2022
    Date of Patent: June 25, 2024
    Assignee: KaliVir Immunotherapeutics, Inc.
    Inventors: Stephen Howard Thorne, Mingrui Zhang
  • Patent number: 11963798
    Abstract: Devices, systems, and methods for quantifying applied pressure by a device against an area of tissue. In particular, the present technology is related to medical devices including an optical element with a fiber Bragg grating, systems including the medical devices, and methods of quantifying applied pressure by the medical device. In one embodiment, a medical device comprises an elongate body including a distal portion and a proximal portion opposite the distal portion, and an optical element located at the distal portion of the elongate body. In one embodiment, the optical element include an optical fiber with a fiber Bragg grating. In one embodiment, the medical device is part of a medical system comprising a control unit in communication with the medical device, the control unit including an optical interrogator in communication with the optical element and processing circuitry configured to receive data from the optical interrogator.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: April 23, 2024
    Assignee: Medtronic, Inc.
    Inventors: Stephen Howard, Carl Schu
  • Patent number: 11963990
    Abstract: The present disclosure provides for recombinant oncolytic viruses with gene deletions or insertions which result in downregulation of Major Histocompatibility Complex class I and alternatively or additively upregulation of Major Histocompatibility Complex class II. Immunologic and pharmaceutical compositions comprising these recombinant viruses and methods of using these compositions are also presented.
    Type: Grant
    Filed: May 24, 2023
    Date of Patent: April 23, 2024
    Assignee: KaliVir Immunotherapeutics, Inc.
    Inventors: Stephen Howard Thorne, Mingrui Zhang
  • Patent number: D1045437
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: October 8, 2024
    Assignee: Textron Innovations Inc.
    Inventors: Jason Michael Decker, Lydia P. Pierce, Stephen Howard Fagan, Merril Binford Williams